title: Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine.
authors.forename: S T
authors.initials: ST
authors.lastname: Ong
authors.forename: H
authors.initials: H
authors.lastname: Koeppen
authors.forename: R A
authors.initials: RA
authors.lastname: Larson
authors.forename: O I
authors.initials: OI
authors.lastname: Olopade
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D000964:Antimetabolites, Antineoplastic; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine; D011241:Prednisone